Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery. Read More >>
targeted therapy
April 19, 2023 · Greg Guthrie, ASCO staff
March 21, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the March 2023 session of the ASCO Plenary Series, which highlights a study evaluating a new targeted therapy drug given in combination with chemotherapy for people with advanced gastric or gastroesophageal junction cancer. Read More >>
February 16, 2023 · Greg Guthrie, ASCO staff
Read about two studies presented at the 2023 Genitourinary Cancers Symposium, covering plant-based diets and prostate cancer and a promising combination treatment for metastatic castration-resistant prostate cancer. Read More >>
February 14, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the February 2023 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapy drugs for treating people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Read More >>
January 25, 2023 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Christopher Flowers discusses new research from the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition, including new treatments for non-Hodgkin lymphoma and models for predicting early disease progression. Read More >>